LAURA PORTER: Open Payments
NPI 1841931771 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 24 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $108 |
| Novo Nordisk Inc | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| Dexcom, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Optinose US, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: REZDIFFRA, REXULTI, Wegovy, JOURNAVX, BREZTRI, VOQUEZNA, Dexcom G6 Transmitter, KEVEYIS.
Industry payments across NY — which companies pay providers there.
